Summary
This 8-K filing from Edwards Lifesciences (EW) details the outcomes of their 2015 Annual Meeting of Stockholders held on May 14, 2015. The most significant information for investors relates to the approval of new and amended executive compensation plans. Stockholders overwhelmingly approved the 2015 Edwards Incentive Plan, which allows for performance-based cash awards to officers and employees, designed to comply with IRS regulations for tax deductibility. Additionally, amendments to the Long-Term Stock Incentive Compensation Program were approved, including an increase in the total number of shares available for issuance under the program. The filing also provides the final voting results for other key proposals, including the election of directors and the ratification of PricewaterhouseCoopers LLP as the independent auditor. The advisory vote on executive compensation (Say-on-Pay) was approved, though a stockholder proposal regarding action by written consent received mixed results. Overall, the meeting's outcomes indicate strong shareholder support for the company's executive compensation framework and governance practices.
Key Highlights
- 1Stockholders approved the 2015 Edwards Incentive Plan, enabling performance-based cash awards for officers and employees, compliant with Section 162(m) of the Internal Revenue Code.
- 2Amendments to the Long-Term Stock Incentive Compensation Program were approved, increasing the aggregate share limit by 2,000,000 shares to a total of 52,900,000 shares.
- 3The limit for restricted stock and restricted stock units under the Long-Term Stock Program was increased by 1,000,000 shares, setting a new total limit of 5,600,000 shares.
- 4All director nominees presented at the 2015 Annual Meeting were elected to serve one-year terms.
- 5The non-binding advisory proposal on executive compensation (Say-on-Pay) was approved by a significant majority.
- 6PricewaterhouseCoopers LLP was ratified as the company's independent public accountants for the fiscal year ending December 31, 2015.
- 7A stockholder proposal regarding action by written consent was not approved by a majority of votes.